Access cutting-edge lung cancer treatment through this clinical trial at a research site in Gilbert. Study-provided care at no cost to qualified participants.
Access lung cancer specialists in Gilbert at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lung cancer treatment provided free
This is a Phase III, randomised, open-label, multicentre, global study assessing the efficacy and safety of adjuvant Dato-DXd in combination with rilvegostomig compared with SoC, after complete surgical resection (R0) in participants with Stage I adenocarcinoma NSCLC who are ctDNA-positive, as determined by the Sponsor-designated ctDNA assay, or have at least one high-risk pathological feature.
Sponsor: AstraZeneca
Check if you qualify for this lung cancer clinical trial in Gilbert, AZ
If you're searching for lung cancer treatment options in Gilbert, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Gilbert research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.